Centene stock: Company reaffirms 2026 EPS guidance
Published on 09/29/2026 at 19:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Centene stock: Centene Corporation reaffirmed its 2026 full-year guidance in a September 16, 2026, Form 8-K filed with the U.S. Securities and Exchange Commission. The filing does not provide a euro quote or percentage change.
2026 earnings guidance reaffirmed
Centene said management reaffirmed full-year 2026 GAAP diluted earnings per share guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4.80 during the Deutsche Bank 2026 Healthcare Summit and subsequent investor discussions through the week of September 21. The filing identified Centene Corporation as the registrant and its common stock as trading under the symbol CNC on the New York Stock Exchange. U.S. Securities and Exchange Commission
Guidance period
The filing stated that the 2026 guidance was effective through September 25, 2026, unless Centene publicly announced updated or reaffirmed guidance. It also described the adjusted EPS measure as a non-GAAP financial measure. U.S. Securities and Exchange Commission
